Myovant Sciences Ltd MYOV

NYS: MYOV | ISIN: BMG637AM1024   9/03/2023
26,98 USD (-0,04%)
(-0,04%)   9/03/2023

29 september 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV · Persbericht

24 oktober 2022 · Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement · Persbericht

16 mei 2022 · Spirovant Launches State-of-the-Art Laboratory and Headquarters · Persbericht

6 mei 2022 · Altavant Sciences Presents Data Showing Potential For Combination Of Rodatristat Ethyl And Ambrisentan In Model Of Pulmonary Arterial Hypertension · Persbericht

2 mei 2022 · Altavant Sciences Presented Data At Ishlt Showing Potency And Distribution Of Bronchiolitis Obliterans Candidate, Alta-2530 · Persbericht

10 februari 2022 · Sumitomo Dainippon Pharma and Sumitovant Biopharma Initiate Phase 1 Study on New Drug Candidate for Carbapenem-Resistant Bacterial Infections · Persbericht

10 december 2021 · Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021 · Persbericht

28 oktober 2021 · Spirovant to Present SP-101 Data at the 2021 North American Cystic Fibrosis Conference · Persbericht

26 mei 2021 · Sumitovant Biopharma Has a Strong Fourth Quarter with Significant Clinical Development and Corporate Achievements Across its Portfolio of Companies · Persbericht

22 februari 2021 · Myovant Sciences to Present at Upcoming Investor Conferences · Persbericht

17 februari 2021 · Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids · Persbericht

17 februari 2021 · Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 · Persbericht

16 februari 2021 · HealthyWomen and Myovant Sciences Launch “Voices of Periods” to Fight Menstrual Stigma · Persbericht

29 januari 2021 · Myovant Sciences to Host Third Fiscal Quarter 2020 Earnings Conference Call at 8:30 a.m. Eastern Time on February 11, 2021 · Persbericht

20 januari 2021 · Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 · Persbericht

5 januari 2021 · CORRECTION -- Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

5 januari 2021 · Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties